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A ~~~ro#~~c ~~~~tr~e for plasmin, ~~~-Gly-Pr~~g-~C~ has bean ~~~~i~ and used to develop 
a new ser&tive photome~c and ~~orome~c assay of p~a~rnino~~ activator activity, The ~or~ce~~ 
i~t~~~ty of &ee AEC a# 450 nm is about 3 orders of rn~~it~de hi&her than that of acyl-AEC. The release 
of AEC from the peptidyl derivative was monitored ~uorometri~ly after extraction of free AEC in 
ethylacetate. Under such conditions, the &, was 0.16 mM. This method was used to monitor the activity 
of plasminogen activator synthetized by fibroblastic elIs (BHK 21 C 13) either eleased in the supernatants 
or cell-associated. 
Syrrthetic fluarogenic substrate 
Fl~~~in~~en activators are found in tissue ex- 
tracts [l], in transformed cell lines [2Jx in primary 
tumors and in secondary tumors or metastases 
[3,4] (see also recent review% IS-?]), PI~minogen 
actiwtors and other proteases are thought a be in- 
volvod in many basic physiolagical phenamena 
such as angiogenesis, cell division, tumor invasion, 
cell spreading and me&static olony development, 
For p~as~nogen activator assay several pro- 
cedures have been described, amongst hem: the 
d~e~~~~~on f soluble ~ptid~s &eased from 
* To whom cm-respondence should be; addressed 
~~~~~~~tjon~: AEC, 3-~ina-q~~ylc~b~le~ CBZ, 
be~~loxy~bony~ pNA, p&roar&e; AMC, 
7-mine-4-methylcoumarine; M+9NA, 4-methoxy-2- 
~ap~thylamide; Boc, f-hut~loxycarb~~y~~ TLC, thin- 
layer c~ornatu~a~hy~ PBS, ph~phat~~b~ffexed saline; 
DMF, ~-dime~y~~or~~de; GEMS Glasgow 
modified Eagle medium 
variuns IaheI~ preens uch as ~~e~~ [g] or 
“‘I-fibrin [!I] in the presence of p~~rni~~g~~~ the 
direct rne~~r~rnent of fluorescent probes released 
from a fhmrogenic substrate such as CBZ- 
Gly-Gly-Arg-AMC [lo] and the calorimetric or 
~uor~rnetr~~ m~~urement of an aromatic aniline 
released from chromogenic or fluoragenic 
substrates such as D-Val-L-Leu-L-Lys-pNA [l l] 
or CBZ~G~y-Pro-~g-~A [12], resp~tiv~l~~ 
in the prestmw of pksminogen, 
Here, we describe a general method allowing 
dete~~at~o~ of pl~minogen aetivatur activity in 
cell ~~~at~~ and in ceft Iysates, on the basis of 
a s~~o~~or~rnetric assay fl3]. This method in- 
voks the use of a fluorogenic substrate CBZ- 
Gly-Pro-ArgWX!, the synthesis of which is 
described, the extraction of the released AEC into 
ethylacetate, the set up of a supplemented culture 
medium free af or poor in plasminogen activators 
and plasmin inhibitors. This method allows deter- 
m~atio~ af the activity of ~~~rn~ogen atiivator 
associated with/or secreted by BH# 21 Cl3 
~brob~~ti~ cells. 
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2. MATERIALS AND METHODS 2.3. Flwrometric measurements 
N-cu-Boc-L-arginine and the dipeptide N-cr- 
CBZ-glycyl-L-prolyl-N-hy~o~su~i~~de ster 
were purchased from B&hem (Bubendorf); 
I-hydroxybenzotriazole monohydrate, 3-amino- 
Q-ethylcarbazole (AEC) and quinine sulfate 
dihydrate were obtained from Aldrich Europe 
(Beerse). AEC was recrystallized from methanol/ 
hexane. 
Fluorescence emission or excitation spectra were 
recorded using a FICA 55 MK II sp~tro~uori- 
meter* The fluorimeter was daily ~and~dized with 
a 0.255 PM quinine sulfate (200 r&ml quinine 
sulfate dihydrate) in 0.1 N HzSO4; upon excitation 
at 345 nm, the fluorescence emission intensity at 
460 nm was taken as 1 fluorescence unit. 
N,N’-dicyclohexylcarbodiimide was from Fluka 
(Buchs) and p-toluene sulfonic acid monohydrate 
from Merck (D~adt). D~e~ylform~de 
was distilled over No-CB~-~y~yl-~-~trophenyl 
ester before use. For thin-layer chromatography 
(TLC) precoated silica gel plates from Merck were 
used. Plasmin from porcine blood was from Sigma 
(St Louis MO); purified human plasminogen from 
‘Centre de Transfusion Sanguine’ (Orsay). Fetal 
bovine serum was obtained fram Flow Labs. Sera 
substitutes: Nu-serum (Collab. Res. s Waltman 
MA), Ultroser G and Ultroser M (Reactifs IBF, 
Pointet Girard, Villeneuve La Garerme). 
The fluorogenic substrate (5 mg) was dissolved 
in N-dimethylformamide (0.2 ml) or in dimethyl- 
sulfoxide and diluted to the appropriate cancentra- 
tion with 50 mM Tris-HCl buffer (pH 8.1). Emis- 
sion and excitation spectra of free and acylated 
AEC were monitored before and after extraction 
with 1 vol. distilled &hyIacetate. 
plasmin 
The kinetic constants were calculated from a 
double-reciprocal p ot by the Lineweaver-Burk 
method based on initial rate determinations at 
23-270yM substrate, in the presence of 1.5 pg 
plasmin/ml, in 50 mM Tris-HCl buffer, pH 8.1 at 
37°C. After 30 min, free AEC was extracted by 1 
vol. ethylacetate and assessed spectrofluorome- 
tricaRy* 
N-LU-Boo-a&nine (1 g) was dissolved in DMF 
containing 1 equiv. p-toluene sulfonic acid and 
condensed with 1 equiv. AEC under nitrogen using 
the classical N,N ‘-dicyclohexylcarbodiimide 
method in the presence of 1-hydroxybenzotriazole. 
N-cr-Boc-arginyl-AEC, p-toluene sulfonate salt, 
was purified by preparative chromatography on a 
silica gel column equilibrated with a 
chloroform/methanol/acetic acid mixture 
{80:20:4, by vol.); RF = 0.35, yield 60%, m,p. 
240°C. 
extracts 
The N-cu-Boc protecting roup was removed by 
HCl/acetic acid to yield HCl, H-arginyl-AEC, p- 
toluene sulfonate, m.p. 227-229°C. 
N+-CBZ-glycyl-L-prolyl-L-arginyl-AEC, p- 
toluene sulfonate was obtained by condensation 
under nitrogen of N-cY-CBZ-glycyl-L-prolyl-N- 
hydroxysuccinimide ester with HCL, H-arginyl- 
AEC, p-toluene sulfonate in DMF in the presence 
of 2 equiv. triethyiamine. 
Baby hamster kidney cells (BHK 21 C 13) were 
grown in GMEM [14] supplemented with 10% 
fetal bovine serum. At appropriate growth density, 
attached cells were washed twice with phosphate- 
buffered saline (PBS) (pH 7.4) and incubated in 
GMEM supplemented with a serum substitute. 
Supernatants were collected after the required time 
lapses and incubated for 3 h in the presence of 
human plasminogen (~~~g~~). In other ex- 
periments, cells were incubated in GMEM sup- 
plemented with a serum substitute in the presence 
of SOpg human plasminogen/ml. In all cases, 
supernatants were assayed for plasminogen ac- 
tivator activity after addition of CBZ- 
Gly-Pro-Arg-AEC (final cont., 0.10 mM), in 
0.05 M Tris-WC1 buffer (pH 8.1) and incubated 
for 45 min at 37°C. 
This compound was purified by preparative 
chromatography using a ~hloroform/methanol~ 
water mixture (90:30: 5, by vol.). 
For the preparation of cell extracts: the-cells 
washed twice with phosphate-buffered saline (PH 
7.4) were removed from the surface by using a rub- 
ber policeman, centrifuged and lysed by incuba- 
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tion in 0.1 M sodium borate (PH 8.5) (1 ml for 2 
x lo6 cells), containing 0.5 g/l polyhydroxy 
alcanoylalkylamine (MAC 14) [ 151. The solution 
was then acidified by adding 1.5 vol. 0.1 M 
glycine-HCl buffer (pH 2.7) containing 0.1% 
gelatin [16]. After 60 min at 37’C, the acid-treated 
lysate was neutralized by adding 1 M Tris-HCl 
buffer (pH 8.1). The lysate (500 pl) was incubated 
for 1 h at 37°C in the presence of plasminogen 
(final cont. 50pg/ml) and finally incubated for 
45 min at 37°C in the presence of CBZ- 
Gly-Pro-Arg-ABC (final cont. 0.1 M). Released 
AEC was extracted with 1 vol. ethylacetate. 
3. RESULTS 
3.1. Characterization and fluorescence properties 
of AEC and CBZ-Gly-Pro-Arg-AEC 
CBZ-Gly-Pro-Arg-ABC synthetized by coupl- 
ing the N-hydroxysuccinimide activated ester of 
CBZ-Gly-Pro with HCI, H-Arg-AEC, p-toluene 
sulfonate was obtained with a 92% yield. The same 
peptide was synthesized only in 40% yield by 
coupling CBZ-Gly-Pro-Arg-OH to AEC in the 
presence of 1-hydroxybenzotriazole and dicyclo- 
hexylcarbodiimide (unpublished). CBZ-Gly-Pro- 
Arg-AEC was homogenous in thin-layer chroma- 
tography, and its NMR, IR, UV and fluorescence 
spectra were in accordance to the expected ones. 
The fluorescence spectrum of CBZ- 
Gly-Pro-Arg-AFC was ideqtical to that of Boc- 
Val-Leu-Gly-Arg-ABC [ 131. After extraction 
with 1 vol. of ethylacetate, 71% of CBZ- 
Gly-Pro-Arg-ABC (initial cont. 0.1 mM) re- 
mained in the aqueous solution. Conversely, 96% 
of AEC was extracted into ethylacetate, under 
similar conditions. In this solvent, the fluorescence 
spectra of free AFX and of CBZ-Gly-Pro-Arg- 
AEC showed excitation maxima at 370 nm and 
345 nm, respectively, and emission maxima at 430 
and 390 nm, respectively (fig.1). The maximum 
fluorescence intensity of ABC in ethylacetate is 
slightly lower than that of AEC in aqueous solu- 
tion. So, after ethylacetate xtraction and upon ex- 
citation at 370 nm, the fluorescence of the acyl- 
AEC derivative at 430 nm was negligible. 
The amount of ABC extracted by ethylacetate 
from a Tris-HCl buffer solution was proportional 
to its initial aqueous concentration over 
Fig.1. Fluorescence mission spectra of free AEC in 
Tris-HCl buffer (pH 8.1) (M) and in ethylacetate 
(O---O), of acyl-AEC in Tris-HCI buffer (pH 8.1) 
(M) and in ethylacetate (O---O). Maximum 
excitation wavelengths of free AEC (6.5 x lo-’ M): 
360 nm in Tris-HCI buffer @H 8.1); 370 nm in 
ethylacetate. Maximum excitation wavelengths of acyl- 
AEC (6.5 x lo-’ M); 340 nm in Tris-HCI buffer 
(pH 8.1); 345 nm in ethylacetate. Temperature 25°C; 
F,, relative fluorescence intensity (arbitrary units). 
0.01-0.05 mM, as shown by fluorescence deter- 
mination (fig.2). 
3.2. Plasmin activity 
Using CBZ-Gly-Pro-Arg-AEC, the K,- and 
V,-values for porcine blood plasmin were 1.6 x 
10m4 M and 0.7 ymol . min-’ . mg-‘, respectively. 
In an initial attempt to use a fluorometric 
method to determine proteolytic activities in a cell 
culture medium, it was found that medium and 
sera contained fluorescent and chromophoric com- 
ov ’ 
OA a2 03 o/ AEC (Io-+T? 
Fig.2. Relative fluorescence intensity (F,, in arbitrary 
units) of AEC in ethylacetate xtracts from Tris-HCI 
solution (pH 8.1) containing different concentrations of 
free AEC. 
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pounds which made any fluorometric method 
insensitive. Knowing that AEC was soluble in 
ethylacetate [13], media and sera were extracted 
with ethylacetate and it was found that no detect- 
able amount of chromophoric or fluorescent com- 
pounds was present in the ethylacetate xtract. 
We had found that the fetal bovine serum and 
Nu-serum hydrolyzed the fluorogenic plasmin 
substrate and that with the Ultroser M serum no 
hydrolysis of the fluorogenic plasmin substrate oc- 
curred (table 1). Furthermore, after acid treat- 
ment, fetal bovine serum and Nu-serum were still 
unsuitable for the determination of the activity of 
plasminogen activator because they were not free 
of either proteolytic activities or plasmin in- 
hibitors. On the contrary, Ultroser M, which con- 
tained neither proteases active on CBZ- 
Gly-Pro-Arg-AEC as substrate nor plasmin in- 
hibitors, allowed further investigations. 
3.3. Activity of plasminogen activator in ceil 
lysates 
The determination of cell-associated 
plasminogen activator requires lysis of the cells. 
Among various detergents (table 2), the poly- 
Table 1 
Proteolytic activity of bovine plasmin in the presence of 
fetal bovine serum or of serum substitutes 
Sera Acid Proteolytic Activity 
treatment activity of added 
(FI) plasmin 
(Q) 
Control - - 100 
Fetal bovine serum - >5 n.d. 
+ 0 0 
Nu-serum - >5 n.d. 
+ 0 4 
Ultroser G >5 n.d. 
+ 0 0 
Ultroser M - 0 100 
+ 0 100 
n.d., not done; F,, relative fluorescence intensity 
Proteolytic activity was determined by measuring the 
fluorescence intensity of the released AEC from 
(0.1 mM) CBZ-Gly-Pro-Arg-AEC after 45 min 
incubation at 37’C. Other experimental conditions are 
in section 2 
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Table 2 
Hydrolysis of CBZ-Gly-Pro-Arg-AEC by plasmin in 
the presence of detergent or surfactants 
Detergent or 
surfactants 
Cont. (g/l) Hydrolysis rate 
(vr) 
Control 100 
Triton X-100 5 0 
Triton X-100 10 0 
MAC-18 5 0 
2.5 0 
MAC-16 5 4 
MAC-14 5 104 
vF, change fluorescence intensity/min, arbitrary units 
CBZ-Gly-Pro-Arg-AEC (0.1 mM) was incubated at 
25°C in the presence of 1 tg bovine plasmin/ml and of 
2.5-10 mg detergent/ml 
hydroxyalkanoyhuninoalkane MAC 14 [ 151 was 
found to be suitable not only to obtain effective 
cell lysis but also to determine the released AEC 
from CBZ-Gly-Pro-Arg-AEC by either plasmin 
or activated plasminogen by plasminogen ac- 
tivator. When CBZ-Gly-Pro-Arg-AEC was in- 
cubated with lo6 BHK 21 C 13 cells lysed in the 
presence of 0.5% MAC 14, free AEC was released 
very rapidly, showing the presence of a cell 
associated plasmin-like activity; this plasmin-like 
activity was quantitatively abolished by an acid 
treatment (60 min, 37”C, pH 2.7) followed by 
Fig.3. Plasminogen activator activity in BHK 21 C 13 
cell lysates: relative fluorescence intensity (FJ of 
released AEC by hydrolysis of CBZ-Gly-Pro-Arg-AEC 
in the presence of plasminogen plus acid-treated cell 
lysate. Average of two independent experiments in 
triplicates, deviation < 10%. 
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Fig.4. Decrease of plasminogen activator activity in cell 
lysates upon cell density increase. F,, relative 
fluorescence intensity of released AEC from a 0.1 mM 
solution of CBZ-Gly-Pro-Arg-AEC, in the presence of 
50/1g plasminogen/ml and of the lysate from 5 x 10’ 
cells. Average of independent expt in triplicate, 
deviation c 10%. 
neutralisation to pH 8.1. Thus, the acid-treated 
MAC 14 lysate was suitable to monitor the activity 
of plasminogen activator, in cell lysate. The 
fluorescence intensity of released AEC from CBZ- 
Gly-Pro-Arg-AEC in the presence of 
plasminogen and acid-treated cell lysate was 
concentration-dependent (fig.3) and lysates from 
5 x 16 cells contained enough plasminogen ac- 
tivator to allow accurate measurements. The 
plasminogen activator activity of acid-treated cell 
lysates on the basis of plasminogen activator ac- 
tivity from a constant number of cells (5 x Id 
cells) decreased when cell density increased (fig.4). 
Fig.5. Activity of plasminogen activator in supernatants 
of BHK 21 C 13 cells. Cells were incubated in GMEM 
supplemented with Ultroser M in the presence of 3Opg 
human plasminogen/ml. After the required time lapse, 
plasmin was determined as in section 2. F,, relative 
fluorescence intensity. 
3.4. Activity of plasminogen activator in ceil 
supernatan t 
No plasminogen activator activity was detected 
in cell supernatant up to 3 h after addition of 
plasminogen in Ultroser M-supplemented medium; 
then, the plasminogen activator activity increased 
rapidly (fig.5). In the absence of plasminogen, no 
plasmin-like activity was detectable ven after 24 h 
incubation in Ultroser M-supplemented medium. 
4. DISCUSSION 
With the aim of setting up a sensitive assay of 
cell-associated proteases and of secreted proteases, 
we have developed new fluorogenic peptides [ 131. 
The specific determination of a given cell protease 
is based on the use of oligopeptides (tri- or 
tetrapeptides). To determine plasminogen ac- 
tivator activity, we selected the sequence CBZ- 
Gly-Pro-Arg which was shown to be specific for 
thrombin [12] and plasmin [17]. Indeed, while 
CBZ-Gly-Pro-Arg-AEC was easily hydrolysed by 
plasmin, it was not hydrolyzed by lOO~g/ml of 
elastase, urokinase or kallikrein (not shown). 
The affinity of CBZ-Gly-Pro-Arg-AEC to por- 
cine plasmin is relatively high as shown by Km = 
0.16 mM which is 3-fold better than the K,,, of 
MeOSu-Ala-Phe-Lys-AMC [ 181, and close to 
the Km of Boc-Val-Leu-Lys-AMC or Boc- 
Gly-Lys-Lys-AMC [ 191. The rate of hydrolysis of 
CBZ-Gly-Pro-Arg-AEC is in the same range as 
those of the above AMC derivatives [19]. Further- 
more, the fluorescence characteristics of free AEC 
and acyl AEC either in aqueous buffer [13] or in 
ethylacetate made this type of derivative very 
suitable for determination of the activity of pro- 
teases. The easy extraction from an aqueous solu- 
tion of free AEC by ethylacetate allows one to stop 
the protease activity and to avoid interferences due 
to fluorescent or chromophoric components pre- 
sent in sera, cell supernatants, or cell lysates. Pro- 
teases which use CBZ-Gly-Pro-Arg-AEC as 
substrate are present in sera [ 121, serum substitutes 
and cell lysates, but are absent from the serum 
substitute Ultroser M. Proteases hydrolysing CBZ- 
Gly-Pro-Arg-AEC and inhibitor present in cell 
lysates were deactivated by the acid treatment pro- 
posed by Loskutoff and Edginton [16] which does 
not seem to alter the activity of plasminogen ac- 
tivator. The medium supplemented with Ultroser 
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Volume 157, number 2 FEBS LETTERS July 1983 
M did not hydrolyse CBZ-Gly-Fro-Arg-AEC; 
under the above conditions, no trace of free AEC 
was detected after 4 h incubation at 37°C. 
Therefore, the measured amount of free ABC after 
45 ruin incubation at 37°C must be due to the celf 
proteases. The use of medium supplemented with 
the aon-interfering serum substitute (_Uhroser M) 
allows cells to grow for 272 h (fig.4). 
The method described allows quantitative deter- 
mination of plasminogen activator activity both in 
cell lysates and cell supernatants. Supernatants 
from 5 x 105 cells did not need to be concentrated 
before the monitoring step, while the direct assay 
described by Z~rne~an et al. [lOI required at 
least a lOO-fold concentra~on. 
The cell-associated plasminogen activator 
detected under the described conditions may also 
include the corresponding proenzyme. Indeed, 
plltlsminogen activator activity was determined by 
activation of plasminogen and therefore if the pro- 
plasminogen activator was present, it should be ac- 
tivated as soon as a trace of plasmin is formed [20]. 
We have described a sensitive fluorometric assay 
which is suitable for monitoring the activity of cell- 
associated plasminogen activator and that present 
in s~~rna~n~* This method is based on the use of 
CBZ-Gly-Pro-Arg-AEC as plasmirr substrate, 
plasmin being produced by specific activation of 
added plasminogen. The released AEC is 
specifically extracted by ethylacetate allowing the 
enzymatic reaction to be stopped and avoiding 
various interferences coming from chromophoric 
and fluorescent compounds present in media, sera 
and cell lysates. The use of a serum substitute such 
as Ultroser M is required to allow cell growth and 
to avoid interferences due to other protease or pro- 
tease inhibitors present in fetal bovine serum. 
Recently, using the same method, it was possible to 
study various aspects of plasminogen activators 
secreted by Lewis lung carcinoma cells from 
primary tumors and metastasis. These data will be 
published elsewhere. Using this method, it was 
possible to monitor the plasminogen activator ac- 
tivity with regard to cell density and cell growth of 
the fibroblastic like BHK 21 C 13 cells. 
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